FDA Approves First Immunotherapy-Companion Diagnostic Combo for Lung Cancer
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
This year, at the AACR Annual Meeting held in Philadelphia April 18 to 22, an astounding 19,300 members of...
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope...
Lung cancer awareness month started hot on the heels of two exciting pieces of news that highlight the promise...
Yesterday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the cancer immunotherapeutic pembrolizumab (Keytruda)...